Study on the changes of thrombosis-associated factors in patients with coronary heart disease of turbidity-phlegm blocking syndrome

Yun-long Wang; Dong-qing An; Ning Ma; Meng Zhu; Hong-yan Sun

doi:10.1007/s11655-009-0337-z

Your Location：

Home >

Browse articles >

Study on the changes of thrombosis-associated factors in patients with coronary heart disease of turbidity-phlegm blocking syndrome

OriginalPaper | Updated：2021-08-27

- Study on the changes of thrombosis-associated factors in patients with coronary heart disease of turbidity-phlegm blocking syndrome
- Study on the changes of thrombosis-associated factors in patients with coronary heart disease of turbidity-phlegm blocking syndrome
- 中国结合医学杂志（英文版） 2009年15卷第5期页码：337-340
- Affiliations：
  
  Traditional Chinese Medicine College of Xinjiang Medical University, Urumiqi,China
- Author bio：
- Funds：
- DOI：10.1007/s11655-009-0337-z
  中图分类号：
- 纸质出版日期：2009，
  
  网络出版日期：2009-10-3，
Scan for full text
Wang, Yl., An, Dq., Ma, N. et al. Study on the changes of thrombosis-associated factors in patients with coronary heart disease of turbidity-phlegm blocking syndrome., Chin. J. Integr. Med. 15, 337–340 (2009). https://doi.org/10.1007/s11655-009-0337-z

Yun-long Wang, Dong-qing An, Ning Ma, et al. Study on the changes of thrombosis-associated factors in patients with coronary heart disease of turbidity-phlegm blocking syndrome[J]. Chinese Journal of Integrative Medicine, 2009,15(5):337-340.
Wang, Yl., An, Dq., Ma, N. et al. Study on the changes of thrombosis-associated factors in patients with coronary heart disease of turbidity-phlegm blocking syndrome., Chin. J. Integr. Med. 15, 337–340 (2009). https://doi.org/10.1007/s11655-009-0337-z DOI：

Yun-long Wang, Dong-qing An, Ning Ma, et al. Study on the changes of thrombosis-associated factors in patients with coronary heart disease of turbidity-phlegm blocking syndrome[J]. Chinese Journal of Integrative Medicine, 2009,15(5):337-340. DOI： 10.1007/s11655-009-0337-z.

摘要

To preliminarily explore the relationship between thrombosis and its associated factors in patients with coronary heart disease (CHD) of turbidity-phlegm blocking syndrome (TPB)

and to study its acting mechanism. Plasma levels of thrombosis-associated factors

including Von Willebrand factor: (vWF)

D-dimer

and fibrinogen (Fg)

in 85 patients of CHD with TPB

93 with CHD of non-TPD

and 89 healthy persons were detected and compared. Levels of the three factors were increased in all the CHD: patients

and were higher in TPB patients than in non-TPB patients (P<0.01 or P<0.05). The TPB: syndrome in CHD patients was closely related to the blood coagulation-fibrinolytic system; they might be in pre-thrombosis state

and the plasma levels of vWF

D-dimer

and Fg could be taken as the objective indices for thrombosis differentiation of TPB syndrome in CHD patients.

Abstract

To preliminarily explore the relationship between thrombosis and its associated factors in patients with coronary heart disease (CHD) of turbidity-phlegm blocking syndrome (TPB)

and to study its acting mechanism. Plasma levels of thrombosis-associated factors

including Von Willebrand factor: (vWF)

D-dimer

and fibrinogen (Fg)

in 85 patients of CHD with TPB

93 with CHD of non-TPD

and 89 healthy persons were detected and compared. Levels of the three factors were increased in all the CHD: patients

and the plasma levels of vWF

D-dimer

and Fg could be taken as the objective indices for thrombosis differentiation of TPB syndrome in CHD patients.

关键词

coronary heart diseaseturbidity-phlegm bocking syndromevon Willebrand factorD-dimerFibrinogen

Keywords

coronary heart diseaseturbidity-phlegm bocking syndromevon Willebrand factorD-dimerFibrinogen

references

Wang ZY, Li JZ, Ruan CG, Song JJ, Wang HL, Han ZC eds. Thrombosis and hemostasis: basic principles and clinical practice. 4th ed. Shanghai: Shanghai Scientific and Technical Publishers; 2004:529–531.

Chinese Society of Cardiovascular Diseases, Chinese Medical Association. Guidance for diagnosis and treatment of chronic stable angina pectonis. Chin J Cardiol (Chin) 2007;35:195–200.

Chinese Society of Cardiovascular Diseases. Guidance for diagnosis and treatment of unstable angina and non-ST elevated myocardial infarction. Chin J Cardiol (Chin) 2007; 36:1–6.

Zheng XY, ed. Guiding principle of clinical research on new drugs of Chinese medicine. Beijng: China Press of Traditional Chinese Medicine; 2002:68–73.

Zhao MF, An DQ. Preliminary investigation on syndromes of dirty phlegm stagnation of chest stuffiness in Xinjiang as well as its prevention and treatment. Xinjiang J Tradit Chin Med (Chin) 2008; 26:84–85.

Morange PE, Simon C, Alessi MC, Luc G, Arveiler D, Ferrieres J, et al. Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study. Circulation 2004;109:1343–1348.

Wang R, Hu DN. Significance of D-dimer and fibrinogen in patients with different kinds of coronary heart disease.Chin Med Herald (Chin) 2006; 35:157–158.

Zheng YS, Zheng QP, Duan LF, Zhang LP. Relationships between plasma D-dimer and coronary heart disease. J Clin Cardiol (Chin) 2004; 20:83–85.

An DQ, Zhao MF, Zheng J, Hu JX. Discussion on chest fullness of phlegm-turbidity stagnation syndrome in Xinjiang. Xinjiang J Tradit Chin Med (Chin) 2007; 2:1–2.

FULL TEXT LINK

More>

浏览量

370

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Effect of Tongmai Jiangzhi oral liquid on serum P-selectin, von Willebrand factors and D-dimer in patients with atherosclerosis

Blood stasis syndrome of coronary heart disease: A perspective of modern medicine

Biomedical mechanisms of blood stasis syndrome of coronary heart disease by systems biology approaches

Study on correspondence between prescription and syndrome and the essence of phlegm and blood stasis syndrome in coronary heart disease based on metabonomics

Summary of 2011 Integrative Medical Doctors Conference